« Back to Record
Awada, A., Bourgeois, P., Cornez, N., Bleiberg, H., Mccabe, S., Gil, T., Lehmann, F., de Valeriola, D., Di Leo, A., Piccart-Gebhart, M., et al. (1999). A clinical pharmacodynamic (Pd) and pharmacokinetic (Pk) phase I study of I.V. R101933, an inhibitor of MDR1 P-glycoprotein (PgP) given alone and in combination with Taxol in patients with solid tumors. Clinical Cancer Research. Vol. 5 (p. 3833) (1999).
Citation APA
Permalink
Permalink
http://hdl.handle.net/2013/ULB-DIPOT:oai:dipot.ulb.ac.be:2013/278631



